Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The imperative for increased investment for an HIV cure.
van Leeuwen R, Barré-Sinoussi F, Müller-Trutwin M, Sáez-Cirión A, Nijhuis M, Lewin SR, Ndung'u T, Riako-Anam F, Warren M, Sikazwe I, Poniatowski B, Grinsztejn B, Kityo C, Davis M, Søgaard OS, Altfeld M, Martinez-Picado J, Vandekerckhove L, Gramatica A, Sok D, Collins S, Yazdanpanah Y. van Leeuwen R, et al. Lancet HIV. 2025 Jul 22:S2352-3018(25)00193-6. doi: 10.1016/S2352-3018(25)00193-6. Online ahead of print. Lancet HIV. 2025. PMID: 40712628 No abstract available.
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.
Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buño A, Castagna A, Girard PM, Chene G, Raffi F, Arribas JR; NEAT001/ANRS143 Study Group. Bernardino JI, et al. Lancet HIV. 2015 Nov;2(11):e464-73. doi: 10.1016/S2352-3018(15)00181-2. Epub 2015 Sep 30. Lancet HIV. 2015. PMID: 26520926 Clinical Trial.
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.
Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chêne G, Pozniak A; NEAT001/ANRS143 Study Group. Raffi F, et al. Among authors: van leeuwen r. Lancet. 2014 Nov 29;384(9958):1942-51. doi: 10.1016/S0140-6736(14)61170-3. Epub 2014 Aug 4. Lancet. 2014. PMID: 25103176 Clinical Trial.
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.
Dickinson L, Gurjar R, Stöhr W, Bonora S, Owen A, D'Avolio A, Cursley A, Molina JM, Fäetkenheuer G, Vandekerckhove L, Di Perri G, Pozniak A, Richert L, Raffi F, Boffito M; NEAT001/ANRS143 Study Group. Dickinson L, et al. J Antimicrob Chemother. 2020 Mar 1;75(3):628-639. doi: 10.1093/jac/dkz479. J Antimicrob Chemother. 2020. PMID: 31754703 Clinical Trial.
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
Lambert-Niclot S, George EC, Pozniak A, White E, Schwimmer C, Jessen H, Johnson M, Dunn D, Perno CF, Clotet B, Plettenberg A, Blaxhult A, Palmisano L, Wittkop L, Calvez V, Marcelin AG, Raffi F; NEAT 001/ANRS 143 Study Group. Lambert-Niclot S, et al. J Antimicrob Chemother. 2016 Apr;71(4):1056-62. doi: 10.1093/jac/dkv427. Epub 2015 Dec 24. J Antimicrob Chemother. 2016. PMID: 26702926 Free article. Clinical Trial.
Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial.
Adegnika AA, de Vries SG, Zinsou FJ, Honkepehedji YJ, Dejon Agobé JC, Vodonou KG, Bikangui R, Bouyoukou Hounkpatin A, Bache EB, Massinga Loembe M, van Leeuwen R, Molemans M, Kremsner PG, Yazdanbakhsh M, Hotez PJ, Bottazzi ME, Li G, Bethony JM, Diemert DJ, Grobusch MP; HookVac Consortium. Adegnika AA, et al. Among authors: van leeuwen r. Lancet Infect Dis. 2021 Feb;21(2):275-285. doi: 10.1016/S1473-3099(20)30288-7. Epub 2020 Sep 11. Lancet Infect Dis. 2021. PMID: 32926834 Clinical Trial.
HERA: a new era for health emergency preparedness in Europe?
Villa S, van Leeuwen R, Gray CC, van der Sande M, Konradsen F, Fröschl G, Nord DG, da Costa CP, Ramirez-Rubio O, Abubakar I, Bärnighausen T, Casamitjana N, Berner-Rodoreda A, Cobelens F, Plasència A, Raviglione M. Villa S, et al. Among authors: van leeuwen r, van der sande m. Lancet. 2021 Jun 5;397(10290):2145-2147. doi: 10.1016/S0140-6736(21)01107-7. Epub 2021 May 18. Lancet. 2021. PMID: 34015340 Free PMC article. No abstract available.
Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial.
Zinsou JF, Diemert DJ, Dejon-Agobé JC, Adégbité BR, Honkpehedji YJ, Vodonou KG, Bikangui R, Edoa JR, Massinga Loembe M, Li G, Yazdanbakhsh M, Bottazzi ME, van Leeuwen R, Kremsner PG, Hotez PJ, Bethony JM, Grobusch MP, Adegnika AA. Zinsou JF, et al. Among authors: van leeuwen r. Lancet Infect Dis. 2024 Jul;24(7):760-774. doi: 10.1016/S1473-3099(24)00104-X. Epub 2024 Mar 18. Lancet Infect Dis. 2024. PMID: 38513684 Clinical Trial.
Where is the 'global' in the European Union's Health Research and Innovation Agenda?
Berner-Rodoreda A, Rehfuess EA, Klipstein-Grobusch K, Cobelens F, Raviglione M, Flahaut A, Casamitjana N, Fröschl G, Skordis-Worral J, Abubakar I, Ashrafian H, Agardh A, Visser L, Schultsz C, Plasència A, Jahn A, Norton R, van Leeuwen R, Hagander L, Bärnighausen T. Berner-Rodoreda A, et al. Among authors: van leeuwen r. BMJ Glob Health. 2019 Oct 3;4(5):e001559. doi: 10.1136/bmjgh-2019-001559. eCollection 2019. BMJ Glob Health. 2019. PMID: 31646008 Free PMC article. Review.
Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy.
Stroeks SLVM, Merlo M, Mora-Ayestaran N, Jason M, Tayal U, Wang P, Cannatà A, Sikking MA, Dal Ferro M, Peiro B, Willemars M, Hellebrekers DMEI, van Leeuwen REW, Setti M, Gonzalez-Lopez E, Krapels IPC, Pio Loco Detto Gava C, van den Wijngaard A, Henkens MTHM, Iseppi M, Raafs AG, Hoes MF, van Empel VPM, Jones EAV, Nabben M, Taylor M, Brunner HG, Ochoa JP, Dominguez F, Lakdawala NK, Sinagra G, Garcia-Pavia P, Mestroni L, Heymans SRB, Verdonschot JAJ. Stroeks SLVM, et al. Among authors: van leeuwen rew. Circ Heart Fail. 2025 Sep 24:e012592. doi: 10.1161/CIRCHEARTFAILURE.124.012592. Online ahead of print. Circ Heart Fail. 2025. PMID: 40988625
399 results